Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 123, Issue 1, Pages 224-235
Publisher
American Society for Clinical Investigation
Online
2012-12-04
DOI
10.1172/jci64516
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition
- (2012) Paramita Chakrabarty et al. Molecular Neurodegeneration
- Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease
- (2011) Chia-Hsiung Chen et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- NF-κB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression
- (2011) Ruitao Wang et al. JOURNAL OF NEUROCHEMISTRY
- GSK-3α/β kinases and amyloid production in vivo
- (2011) Tomasz Jaworski et al. NATURE
- Aβ1–42 inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β
- (2011) Jihoon Jo et al. NATURE NEUROSCIENCE
- GSK-3: Functional Insights from Cell Biology and Animal Models
- (2011) Oksana Kaidanovich-Beilin et al. Frontiers in Molecular Neuroscience
- Inflammation in neurodegenerative diseases
- (2010) Sandra Amor et al. IMMUNOLOGY
- BACE1 Gene Promoter Single-Nucleotide Polymorphisms in Alzheimer’s Disease
- (2010) Weihui Zhou et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer’s Disease
- (2010) Piet Eikelenboom et al. Neurodegenerative Diseases
- Powerful beneficial effects of macrophage colony-stimulating factor on -amyloid deposition and cognitive impairment in Alzheimer's disease
- (2009) V. Boissonneault et al. BRAIN
- Massive gliosis induced by interleukin-6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition
- (2009) Paramita Chakrabarty et al. FASEB JOURNAL
- Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain
- (2009) Eléonore Beurel et al. Journal of Neuroinflammation
- Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity
- (2008) Christopher J. Yuskaitis et al. CELLULAR SIGNALLING
- Differential Regulation of STAT Family Members by Glycogen Synthase Kinase-3
- (2008) Eléonore Beurel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NFκB-dependent Control ofBACE1Promoter Transactivation by Aβ42
- (2008) Virginie Buggia-Prevot et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models
- (2008) Hong Qing et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of -Site Amyloid Precursor Protein-Cleaving Enzyme 1
- (2008) W.-X. Wang et al. JOURNAL OF NEUROSCIENCE
- Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer's Disease
- (2008) M. A. Busche et al. SCIENCE
- The Mood-Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase-3
- (2003) Guang Chen et al. JOURNAL OF NEUROCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started